Pancreatin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10,000, 25,000, 40,000, 50,000, 80,000 USP units.
Reference Brands: Creon(US)
Category:
Gastrointestinal Drugs
Pancreatin tablets contain digestive enzymes—amylase, lipase, and protease—that assist in break down carbohydrates, fats, and proteins. They improve nutrient absorption, reduce digestive discomfort, and support recovery in pancreatic insufficiency. Benefits include better digestion, symptom relief, and improved nutritional status for patients with pancreatitis or enzyme deficiencies.
Pancreatin Tablets is available in Tablets
and strengths such as 10,000, 25,000, 40,000, 50,000, 80,000 USP units..
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pancreatin Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pancreatin Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Pancreatin tablets, containing essential digestive enzymes, are approved in the US by the FDA and in the EU via EMA for pancreatic enzyme replacement therapy in pancreatitis and pancreatic insufficiency. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures regional safety, efficacy, and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports swift approval, safe use, and broad availability of pancreatin tablets, helping improve digestion and nutritional health worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing